Letter | Published:

Long-term correction of rat model of Parkinson's disease by gene therapy

Nature volume 362, pages 450453 (01 April 1993) | Download Citation

Subjects

Abstract

THE implantation of cells genetically modified to express tyrosine hydroxylase has been proposed for the treatment of Parkinson's disease1. Tyrosine hydroxylase converts tyrosine to L-DOPA and endogenous decarboxylase activity then converts L-DOPA to the neurotransmitter dopamine, which alleviates the symptoms of Parkinson's disease. Immortalized cells have been successfully used as intracerebral vehicles for transgene expression of tyrosine hydroxylase, but the tumorigenic potential of these cells prevents their application in humans1–4. Intracerebral expression of this enzyme has also been achieved using primary cells like skin fibroblasts5–7, but the ameliorating effect on a rat model for Parkinson's disease lasted for only a few weeks. We have found that co-transplantation of cultured myoblasts and myotubes enabled reporter genes to be expressed intracerebrally at high and stable levels8–10. Here we show that the intracerebral transplantation of plasmid-transfected primary muscle cells can substantially reduce for the long-term the asymmetric rotational behaviour in the rat model.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    et al. Proc. natn. Acad Sci. U.S.A. 86, 9011–9014 (1989).

  2. 2.

    et al. Neuron. 5, 393–402 (1990).

  3. 3.

    et al. J. Neurosci. Res. 25, 405–411 (1990).

  4. 4.

    et al. Neuroscience 23, 795–807 (1987).

  5. 5.

    & et al. Neuron 6, 1–12 (1991).

  6. 6.

    et al. Neuron 6, 371–380 (1991).

  7. 7.

    et al. J. cell. Biochem. 45, 252–257 (1991).

  8. 8.

    , & Brain Res. 575, 143–147 (1992).

  9. 9.

    et al. Cell Transpl. (in the press).

  10. 10.

    & Neurosci. Lett. 137, 207–210 (1992).

  11. 11.

    et al. Hum. Molec. Genet. 1, 363–369 (1992).

  12. 12.

    & Nature 359, 733–736 (1992).

  13. 13.

    & Acta neurol Scand. 126, 183–187 (1989).

  14. 14.

    , & J. Neurochem. 39, 1152–1162 (1982).

  15. 15.

    , & Brain Res. 386, 209–222 (1986).

  16. 16.

    , , & Proc. natn. Acad. Sci. U.S.A. 88, 1330–1334 (1991).

  17. 17.

    in Handbook of Parkinson's Disease (ed. Koller, W. C.) 355–370 (Dekker, New York, 1987).

  18. 18.

    , & J. Chromat. 567, 351–358 (1991).

  19. 19.

    , & J. Chromat. 167, 219–230 (1978).

  20. 20.

    & J. Chromat. 213, 429–437 (1981).

  21. 21.

    & Molec. cell. Biol. 5, 281–290 (1985).

  22. 22.

    , & Biochemistry 26, 5208–5212 (1987).

  23. 23.

    & The Rat Brain in Stereotaxic Coordinates (Academic, New York, 1982).

  24. 24.

    et al. Science 204, 643–647 (1979).

Download references

Author information

Author notes

    • Jon A. Wolff

    To whom correspondence should be addressed.

Affiliations

  1. Departments of Pediatrics and Medical Genetics, Waisman Center, University of Wisconsin, Madison, Wisconsin 53705, USA

    • Shoushu Jiao
    • , Vladimir Gurevich
    •  & Jon A. Wolff

Authors

  1. Search for Shoushu Jiao in:

  2. Search for Vladimir Gurevich in:

  3. Search for Jon A. Wolff in:

About this article

Publication history

Received

Accepted

Published

DOI

https://doi.org/10.1038/362450a0

Further reading

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.